
Igor D. Bandeira MD PhD
Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine
Join to View Full Profile
3550 Market StSan Francisco, CA 94131
Dr. D. Bandeira is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Stanford UniversityPost-Doctoral Fellowship, 2021
- Federal University of Bahia Faculty of MedicineDoctor of Philosophy, Clinical Neuroscience, 2019 - 2021
- Federal University of Bahia Faculty of MedicineClass of 2018
Awards, Honors, & Recognition
- New Investigator Award International Society for CNS Clinical Trials and Methodology, 2025
- Alies Muskin Career Development Leadership Program Award Anxiety and Depression Association of America, 2025
- Travel Fellowship Award Winter Conference on Brain Research, 2025
- Join now to see all
Clinical Trials
- Opiate Suicide Study in Patients With Major Depression Start of enrollment: 2020 Aug 01
- Personalized Therapeutic Neuromodulation for Anhedonic Depression Start of enrollment: 2022 May 31
- Rapid Acting TMS for Suicide Ideation in Depression Start of enrollment: 2021 Nov 07
- Join now to see all
Publications & Presentations
PubMed
- Early differences in lassitude predicts outcomes in Stanford Neuromodulation Therapy for difficult to treat depression.David Benrimoh, Azeezat Azeez, Jean-Marie Batail, Xiaoqian Xiao, Derrick Buchanan
Npj Mental Health Research. 2024-10-28 - 1 citationsEsketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review.Raíza Alves-Pereira, Mariana Fontes, Vivian Cordeiro, Igor D Bandeira, Daniela Faria-Guimarães
Clinical Neuropharmacology. 2024-01-02 - 5 citationsDoes the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secon...Mariana V F Echegaray, Rodrigo P Mello, Guilherme M Magnavita, Gustavo C Leal, Fernanda S Correia-Melo
Trends in Psychiatry and Psychotherapy. 2023-09-17
Other Languages
- Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: